
PolarityTE, Inc. (PTE)
ValueMarkers Composite Index
DCF data not available
PolarityTE, Inc. (PTE) — VMCI valuation read
Composite valuation read on PTE: VMCI 57/100 against a Healthcare sector median of 50. The 7-point above-median print is the headline number for PolarityTE, Inc., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.
Trailing 30-day insider activity for PTE: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.
**Investor frame.** Value, quality, risk in three lines on PTE: PTE trades at 19.0x earnings, 6% above the Healthcare median of 18.0x; ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp; net debt to EBITDA of 0.9x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.
PTE rose 2.0% over the trailing 7 days, with a -5.4% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.
- EGRX - Eagle Pharmaceuticals, Inc.
- EGRX - Eagle Pharmaceuticals, Inc.
- MHUA - Meihua International Medical Technologies Co., Ltd.
- MHUA - Meihua International Medical Technologies Co., Ltd.
- IIG.MI - Italia Independent Group S.p.A.
- XII.JO - Numeral Limited
- NIVF - NewGenIvf Group Limited
- NIVF - NewGenIvf Group Limited